News & Events :: Can-Fite BioPharma Ltd. (CANF)

Recent News View All News

Apr 30, 2026 8:31am EDT

Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

Mar 30, 2026 7:20am EDT

Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026

Upcoming Events View IR Calendar

May 28, 2026 3:00 pm IDT

2026 Annual General Meeting of Shareholders

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings